Biohaven Pharmaceutical Holding Co Ltd. Business Finance Contracts & Agreements
29 Contracts & Agreements
- Credit Agreements (1 contract)
- Equity Distribution Agreements (1)
- Exchange Agreements (1)
- Financing Agreements (2)
- Funding Agreements (2)
- Investor Rights Agreements (1)
- Note Agreements (1)
- Purchase Agreements (3)
- Registration Rights Agreements (1)
- Share Agreements (3)
- Stock Agreements (2)
- Subscription Agreements (3)
- Underwriting Agreements (5)
- Warrant Agreements (3)
- Membership Interest Purchase Agreement, dated as of February 24, 2022, by and among Biohaven Therapeutics LTD., Knopp Biosciences LLC, Channel Biosciences, LLC and Biohaven... (Filed With SEC on May 10, 2022)
- Amendment No. 4 to Financing Agreement, dated as of December 28, 2021, by and between Biohaven Pharmaceuticals Holding Company Ltd., Biohaven Pharmaceuticals, Inc., the guarantors... (Filed With SEC on February 25, 2022)
- Amendment No. 3 and Limited Consent to Financing Agreement, dated November 9, 2021, by and between Biohaven Pharmaceuticals Holding Company Ltd., Biohaven Pharmaceuticals, Inc.,... (Filed With SEC on November 12, 2021)
- Subscription Agreement, dated November 9, 2021, by and between Pfizer Inc. and Biohaven Pharmaceutical Holding Company Ltd (Filed With SEC on November 12, 2021)
- Underwriting Agreement, dated as of March 15, 2021, by and between the Company and Goldman Sachs & Co. LLC (Filed With SEC on March 17, 2021)
- Equity Distribution Agreement, dated as of December 23, 2020, by and between Biohaven Pharmaceutical Holding Company Ltd. and Goldman Sachs & Co. LLC, Piper Sandler & Co., SVB... (Filed With SEC on December 23, 2020)
- Series B Preferred Share Purchase Agreement by and (Filed With SEC on November 9, 2020)
- Funding Agreement by and (Filed With SEC on November 9, 2020)
- Offer Letter dated April 5, 2017 by and between Biohaven Pharmaceuticals, Inc. and Elyse Stock (Filed With SEC on February 26, 2020)
- Underwriting Agreement, dated as of January 28, 2020, by and between the Company and Goldman Sachs & Co. LLC (Filed With SEC on January 30, 2020)
- Underwriting Agreement, dated as of June 18, 2019 by and among the Company and Goldman Sachs & Co. LLC and Piper Jaffray & Co., as Representatives of the several Underwriters... (Filed With SEC on June 21, 2019)
- Series A Preferred Share Purchase Agreement, dated as of March 18, 2019 (Filed With SEC on May 8, 2019)
- Form of Underwriting Agreement (Filed With SEC on December 10, 2018)
- Funding Agreement, dated June 18, 2018, by and between Biohaven Pharmaceutical Holding Company Ltd. and RPI Finance Trust (Filed With SEC on June 25, 2018)
- Registration Rights Agreement, dated March 9, 2018 (Filed With SEC on March 12, 2018)
- Securities Purchase Agreement, dated March 9, 2018 (Filed With SEC on March 12, 2018)
- Second Subscription Agreement between Kleo Pharmaceuticals, Inc. and the Registrant, dated as of October 5, 2017 (Filed With SEC on October 12, 2017)
- First Subscription Agreement between Kleo Pharmaceuticals, Inc. and the Registrant, dated as of October 5, 2017 (Filed With SEC on October 12, 2017)
- SECURITIES PURCHASE AGREEMENT BETWEEN KLEO PHARMACEUTICALS, INC. AND BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LIMITED. Dated as of August 29, 2016 (Filed With SEC on June 14, 2017)
- BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. 2017 EMPLOYEE SHARE PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS: APRIL 6, 2017 APPROVED BY THE SHAREHOLDERS: [ ] (Filed With SEC on April 24, 2017)
- Shares BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. COMMON SHARES, WITHOUT PAR VALUE UNDERWRITING AGREEMENT (Filed With SEC on April 24, 2017)
- CREDIT AGREEMENT (Filed With SEC on April 7, 2017)
- LICENSE AGREEMENT between BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. and BRISTOL-MYERS SQUIBB COMPANY CONFIDENTIAL TREATMENT HAS BEEN REQUESTED FOR PORTIONS OF THIS EXHIBIT. THE... (Filed With SEC on April 7, 2017)
- WARRANT No. 1 (Filed With SEC on April 7, 2017)
- WARRANT No. 4 (Filed With SEC on April 7, 2017)
- WARRANT No. 3 (Filed With SEC on April 7, 2017)
- TERM NOTE (Filed With SEC on April 7, 2017)
- BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. INVESTORS RIGHTS AGREEMENT October 28, 2016 (Filed With SEC on April 7, 2017)
- Common Stock Purchase Agreement, dated June 18, 2018, by and between Biohaven Pharmaceutical Holding Company Ltd. and RPI Finance Trust (Filed With SEC on June 25, 2018)
